June 23, 2025 11:53 AM EDTUpdated 12:49 PM
Pharma
Law

Supreme Court asks DOJ to weigh in on Hik­ma ‘skin­ny la­bel’ fight against Amarin

Alexis Kramer

Deputy Editor

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Act­ing CDER chief is leav­ing af­ter al­most nine years at FDA

No­vo ends short-lived part­ner­ship with Hims over com­pound­ed obe­si­ty drugs

Am­gen plans more grad­ual Mar­i­Tide dos­ing in Phase 3 

Hims and No­vo Nordisk part­ner to of­fer dis­count­ed We­govy

Ex­elix­is' pos­i­tive Phase 3 col­orec­tal can­cer da­ta boost stock

sponsored

Dig­i­tal Twins in GMP Man­u­fac­tur­ing: Shap­ing the Fu­ture of CPV with Aizon

A service from the Financial Times